Sharmini Alagaratnam

573 citations
14 papers · 408 indexed · h-index 10

Sharmini Alagaratnam

14 papers receiving 402 citations

Peers

Sharmini Alagaratnam
Comparison fields: 5 of 49
  • Reproductive Medicine 46
  • Cancer Research 80
  • Molecular Biology 271
  • Oncology 74
  • Pathology and Forensic Medicine 46
Replace Yong Sam Shin with:
Yong Sam Shin South Korea
Rana Abdel‐Fattah United States
A Koch Germany
Kari J. Brewer Savannah United States
Mary Taglienti United States
Suiqun Guo China
María C. de Marco Spain
Astrid Escudero‐Esparza United Kingdom
Marta Llauradó Spain
Roberto Rosati Italy
Sharmini Alagaratnam relative to Yong Sam Shin South Korea Yong Sam Shin's profile →
Citations per field
00.5×
Yong Sam Shin · 1×
Citations per year

Countries citing papers authored by Sharmini Alagaratnam

Since Specialization
Citations

This map shows the geographic impact of Sharmini Alagaratnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmini Alagaratnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmini Alagaratnam more than expected).

Fields of papers citing papers by Sharmini Alagaratnam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmini Alagaratnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmini Alagaratnam. The network helps show where Sharmini Alagaratnam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sharmini Alagaratnam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sharmini Alagaratnam Line = papers co-authored together Sharmini Alagaratnam links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 202011
2 20205
3 201920
4 201647
5 20161
6 201519
7 201513
8 2013115
9 201367
10 201211
11 20128
12 201138
13 200847
14 20086

About Sharmini Alagaratnam

Sharmini Alagaratnam is a scholar working on Cancer Research, Reproductive Medicine and Genetics, having authored 14 papers that have together received 408 indexed citations. Recurring topics across this work include Testicular diseases and treatments (5 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers), Cancer Genomics and Diagnostics (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Pluripotent Stem Cells Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), CRISPR and Genetic Engineering (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Reproductive Medicine (46 citations), Cancer Research (80 citations) and Molecular Biology (271 citations). Sharmini Alagaratnam has collaborated with scholars based in Norway, United Kingdom and Netherlands. Frequent co-authors include Ragnhild A. Lothe, Rolf I. Skotheim, Sigrid Marie Kraggerud, Peter W. Andrews, Paul Robson, Christina Engel Hoei‐Hansen, Stuart Avery, Duncan Baker, Alan Colman and Barbara B. Knowles. Their work appears in journals such as Journal of Clinical Oncology, Endocrine Reviews and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026